Nearly 4 million deaths among women and children in sub-Saharan Africa could be prevented annually if relatively inexpensive, “science-based health policies” reached 90 percent of Africans, according to an African Science Academy Development Initiative (ASADI) report (.pdf) published Monday, Nature News reports. The report, which is the initiative’s first policy paper, was released at the group’s fifth annual conference in Accra, Ghana, from Nov. 9-11.
Also In Global Health News: Home HIV Treatment; Voluntary Testing In Kenya; Women/HIV Scorecard; Global Fund Zimbabwe Grant; Contraceptives In Tanzania
Home Vs. Clinic Treatment of HIV In Uganda The New York Times reports on a Lancet studyÂ that found treating Ugandan HIV patients at home is cheaper and just as effective as treating them in a clinic. “The finding is important because five million more Africans will need AIDS drugs in…
With the disease burden of AIDS, tuberculosis, and malaria expected to make up less than 15 percent of the total disease burden in sub-Saharan Africa (SSA) by 2030, and non-communicable diseases to account for nearly 40 percent of the total in the region, “[a] revision of the approach to research and health care in SSA is therefore urgently needed, but international donors and health communities have generally been slow to respond to the changing environment,” Ole Olesen and M. Iqbal Parker of the International Centre for Genetic Engineering and Biotechnology in South Africa write in a commentary in Tropical Medicine & International Health. “Private and public funding for health research in Africa remains therefore disproportionately focused on the three major infectious diseases, whereas only smaller amounts have been allocated to confront other diseases,” they write and provide examples.
“Chagas disease, a parasitic infection spread to humans by insects, is not the new HIV/AIDS of the Americas, according to infectious disease experts who called the comparison,” made in an editorial published in PLoS Neglected Tropical Diseases last week, “‘unrealistic’ and ‘unfortunate,’” ABC News’ “Medical Unit” blog reports. “Rick Tarleton, president of the Chagas Disease Foundation, said the diseases have little in common beyond disproportionately affecting poor people,” the blog notes (Moisse, 6/1).
Congressman 'Dissatisfied' With Handling Of Controversial H5N1 Papers Calls For Cohesive Policy For Handling 'Risky' Research
“[D]issatisfied with the government’s handling of two research papers on mutant forms of avian influenza,” Rep. Jim Sensenbrenner (R-Wisc.) on Wednesday “said that the lack of a cohesive policy for handling risky research funded by the National Institutes of Health (NIH) and other federal agencies could necessitate new laws, a situation that researchers have been trying to avoid,” the Nature News Blog reports. “The second of the controversial papers showing that H5N1, or ‘bird flu,’ can spread through the air between mammals was published last week, providing some closure to the months-long debate about the work and whether its publication would result in the proliferation of dangerous viruses and increased risk of an accidental or intentional release,” the blog writes, adding, “Sensenbrenner says not enough work has been done to ensure that such controversies don’t arise again.”
Ghana “will contribute about $1 million towards the prevention and control of endemic neglected tropical diseases (NTDs) in order to protect the gains made by the country in Guinea worm eradication and the elimination of trachoma,” the country’s health minister announced on Monday at the opening of a Regional Stakeholders’ Consultative Meeting on NTDs, PANA/AfriqueJet reports. Health Minister Albin Bagbin “also called on African countries to support interventions to address NTDs and improve coordination among all stakeholders in implementing NTD programs,” the news agency writes.
Reuters examines how the fight against malaria in Africa is helping to fuel the continent’s economic growth. “The number of malaria deaths has fallen dramatically in the last decade due to increased aid spending on basic items such as insecticide-treated bed nets and drugs, the World Health Organization (WHO) says,” the news agency writes, noting that an experimental vaccine from GlaxoSmithKline is showing prospect. The news agency discusses the efforts of AngloGold Ashanti, the world’s third largest gold producer, to prevent and treat malaria among its workers, which “‘made economic sense because of the absenteeism and the cost of medication,’ said Steve Knowles, the head of AngloGold’s anti-malaria operations.”
“It’s easy to get the impression that [recent controversy over research into mutated versions of the H5N1 flu virus] has created a clear split between a scientific community that wants the research to proceed and the results to be published and a biosecurity community that doesn’t,” biological-weapons expert Tim Trevan writes in this Nature opinion piece. But “[a]s a member of this biosecurity community for more than 30 years — I was special adviser to the chairman of the United Nations weapons inspectors in Iraq and covered chemical and biological disarmament with the U.K. Foreign Office in both London and Geneva, Switzerland — I believe this to be a false dichotomy,” he states.
“In order to break the vicious cycle that leaves tropical diseases neglected, existing programs that diagnose and treat patients need to be expanded and medical research to develop simpler, more effective tools needs to be supported, according to a new report, Fighting Neglect [.pdf], released [Monday] by Medecins Sans Frontieres/Doctors Without Borders (MSF),” the organization reports on its webpage. “Charting the organization’s 25 years of experience in diagnosing and treating Chagas disease, sleeping sickness, and kala azar in Latin America, sub-Saharan Africa, South Asia and the Caucasus, the report examines past, present, and future management of the diseases and notes that access to quality life-saving treatment requires much greater political will among major international donors and national governments of endemic countries,” MSF writes (6/11).
“Scientists on Sunday said they had found a key piece in the puzzle as to why a tiny minority of individuals infected with HIV have a natural ability to fight off the deadly AIDS virus,” Agence France-Presse reports. “In a study they said holds promise for an HIV vaccine, researchers from four countries reported the secret lies not in the number of infection-killing cells a person has, but in how well they work,” AFP writes. “Only about one person in 300 has the ability to control the human immunodeficiency virus (HIV) without drugs” the news service notes (6/10).